INDUSTRY: Healthcare/Life Sciences
Tags:
How Accelirate’s AI Agent-Powered Donor Screening Platform Cuts Manual Work by 70% and Screening Time by 50% for a Leading Life Sciences Company
70%
lesser manual screening workload
50%
faster screening (from 90 mins to 45 mins)
95%
AI decision accuracy
100%
HIPAA compliance
24/7
scalability without additional staffing
Client Overview
The client is a leading Life Sciences company providing donor screening services to tissue recovery agencies. Their donor eligibility process relied heavily on manual hotline calls, paper-based assessments, and human review of medical records, resulting in delays, inconsistencies, and operational inefficiencies. With growing demand, the client sought a modernized, compliant, and scalable digital solution capable of delivering faster and more accurate screening decisions.
Key Takeaways
- Designed and deployed an AI agent-powered donor screening platform leveraging LLMs and document intelligence
- Automated extraction, interpretation, and decision-making for donor eligibility
- Integrated human-in-the-loop validation for complex cases
- Achieved 70% workload reduction and 50% faster decision-making
- Maintained strict HIPAA compliance and transparency with detailed audit logs
The traditional donor screening process was heavily reliant on manual intervention, leading to delayed eligibility decisions, inconsistent interpretations, and limited scalability. Staff members had to review medical documents, assess risk factors, and complete lengthy donor questionnaires, often under tight timelines.
To modernize this process, Accelirate collaborated with the client to develop an AI-powered donor screening platform using large language models (LLMs), document intelligence, and AI Agents. This intelligent system automated the review, classification, and decision process while ensuring every action was auditable, explainable, and compliant with healthcare regulations.
Modernizing Donor Risk Assessment with AI and Data Intelligence
The donor screening process at the Life Sciences company was complicated and prone to delays. Staff members manually reviewed Universal Donor Risk Assessment Interviews (UDRAI), medical records, and other documentation, an approach that often resulted in inconsistent eligibility decisions and extended turnaround times. As case volumes grew, the existing process could no longer sustain operational demand. The lack of a unified digital platform made it difficult to extract critical information quickly, while compliance requirements around HIPAA added layers of complexity and manual verification. This led to inefficiencies, reduced productivity, and delayed donor eligibility confirmations, ultimately affecting the speed at which tissue recovery agencies could proceed with time-sensitive operations.
To address these challenges, Accelirate implemented an AI-powered, HIPAA-compliant web platform that brought intelligence, speed, and precision to donor screening:
01 - Document Intelligence AI
Automatically extracted and analyzed data from Universal Donor Risk Assessment Interviews (UDRAI) and medical reports.
02 - LLM-Powered Decision Engine
Interpreted complex information and compared it against dynamic eligibility criteria to determine donor acceptance or deferral.
03 - AI Agent Escalation System
Flagged ambiguous or complex cases for human review, maintaining oversight and compliance.
04 - Line-by-Line Rationale Generation
Delivered transparent, auditable explanations for every decision.
05 - Scalable 24/7 Web Portal
Enabled round-the-clock screening without manual delays.
What Was Unique About the Solution That Was Implemented?
Unlike traditional automation tools, Accelirate’s solution used Large Language Models (LLMs) and AI Agents to bring contextual understanding, interpretive reasoning, and compliance-driven intelligence into a highly regulated process. This combination of AI intelligence and human oversight set a new benchmark for trust, accuracy, and scalability in healthcare automation.
The uniqueness lay in its ability to:
- Evaluate complex donor information using LLM comprehension, not rigid rules
- Generate transparent, explainable decisions with detailed rationales
- Maintain 100% HIPAA compliance while handling sensitive medical data
- Seamlessly integrate human review checkpoints for critical cases
- Scale operations for 24/7 AI-enabled donor screening
Achieving New Benchmarks in Efficiency and Trust with AI Intelligence
By automating the most time-intensive parts of the donor screening process, the client achieved a massive improvement in efficiency, accuracy, and scalability. The AI-powered platform transformed operations from reactive manual reviews to proactive, data-driven screening, ensuring faster decisions without compromising compliance or safety.
Key Results:
1. 70% Reduction in Manual Effort
The AI now performs most data extraction and analysis, freeing staff for complex reviews.
2. 50% Faster Turnaround Time
Screening time reduced from 90 minutes to 45 minutes per case.
3. 95% AI Accuracy Rate
LLM-driven interpretation matched human-reviewed accuracy during pilot testing.
4. 100% Compliance Assurance
Every decision includes audit trails explaining the rationale, ensuring traceability.
5. Scalable 24/7 Screening
AI enables continuous operations without additional headcount.
Product / AI Agent Spotlight
The Accelirate AI-Powered Donor Screening Agent combines LLMs, document intelligence, and agentic automation to enable accurate, compliant, and scalable donor screening. It automatically reads medical forms, interprets donor risk factors, and evaluates eligibility in real time.
With built-in human-in-the-loop validation, it ensures that sensitive or complex cases receive expert reviews. Fully compliant with HIPAA standards, this AI Agent supports secure, transparent, and high-speed decision-making, helping life sciences organizations improve throughput and maintain trust at scale.
Empowering Healthcare and Life Sciences Teams with Trusted AI
This success story outlines how Accelirate’s Agentforce AI Agent-powered reverification solution transformed pharmacy benefits validation for the client. By reducing manual effort, cutting prescription delays, and improving coverage accuracy, the client not only enhanced member experience but also built stronger provider trust and operational efficiency.
Accelirate’s innovation not only modernized donor screening but also demonstrated how AI can deliver trustworthy, auditable, and real-world impact in highly regulated environments.
If your organization seeks to achieve similar operational excellence and compliance assurance, associate with us to build custom AI Agent solutions that optimize your workflows, reduce effort, and ensure accuracy at scale. Connect with us today to get started!
Need a Quick Reference?
Download the mini version of our case study for easy sharing with your team.
Explore Our Featured Case Studies
